A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.

The global Prokinetic Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Prokinetic Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prokinetic Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Prokinetic Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prokinetic Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Prokinetic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Prokinetic Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Prokinetic Drug Market Report

Report Metric	Details
Report Name	Prokinetic Drug Market
CAGR	5%
Segment by Type	Metoclopramide Domperidone Cisapride Others
Segment by Application	Gastroparesis Constipation Reflux Esophagitis Functional Dyspepsia
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Prokinetic Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prokinetic Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prokinetic Drug Market report?

Ans: The main players in the Prokinetic Drug Market are Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm

What are the Application segmentation covered in the Prokinetic Drug Market report?

Ans: The Applications covered in the Prokinetic Drug Market report are Gastroparesis, Constipation, Reflux Esophagitis, Functional Dyspepsia

What are the Type segmentation covered in the Prokinetic Drug Market report?

Ans: The Types covered in the Prokinetic Drug Market report are Metoclopramide, Domperidone, Cisapride, Others

1 Study Coverage

1.1 Prokinetic Drug Product Introduction

1.2 Market by Type

1.2.1 Global Prokinetic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Metoclopramide

1.2.3 Domperidone

1.2.4 Cisapride

1.2.5 Others

1.3 Market by Application

1.3.1 Global Prokinetic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Gastroparesis

1.3.3 Constipation

1.3.4 Reflux Esophagitis

1.3.5 Functional Dyspepsia

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Prokinetic Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Prokinetic Drug Revenue by Region

2.2.1 Global Prokinetic Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Prokinetic Drug Revenue by Region (2019-2024)

2.2.3 Global Prokinetic Drug Revenue by Region (2025-2030)

2.2.4 Global Prokinetic Drug Revenue Market Share by Region (2019-2030)

2.3 Global Prokinetic Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Prokinetic Drug Sales by Region

2.4.1 Global Prokinetic Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Prokinetic Drug Sales by Region (2019-2024)

2.4.3 Global Prokinetic Drug Sales by Region (2025-2030)

2.4.4 Global Prokinetic Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Prokinetic Drug Sales by Manufacturers

3.1.1 Global Prokinetic Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Prokinetic Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prokinetic Drug in 2023

3.2 Global Prokinetic Drug Revenue by Manufacturers

3.2.1 Global Prokinetic Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Prokinetic Drug Revenue in 2023

3.3 Global Key Players of Prokinetic Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Prokinetic Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Prokinetic Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Prokinetic Drug, Product Offered and Application

3.8 Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Prokinetic Drug Sales by Type

4.1.1 Global Prokinetic Drug Historical Sales by Type (2019-2024)

4.1.2 Global Prokinetic Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Prokinetic Drug Sales Market Share by Type (2019-2030)

4.2 Global Prokinetic Drug Revenue by Type

4.2.1 Global Prokinetic Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Prokinetic Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2019-2030)

4.3 Global Prokinetic Drug Price by Type

4.3.1 Global Prokinetic Drug Price by Type (2019-2024)

4.3.2 Global Prokinetic Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Prokinetic Drug Sales by Application

5.1.1 Global Prokinetic Drug Historical Sales by Application (2019-2024)

5.1.2 Global Prokinetic Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Prokinetic Drug Sales Market Share by Application (2019-2030)

5.2 Global Prokinetic Drug Revenue by Application

5.2.1 Global Prokinetic Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Prokinetic Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2019-2030)

5.3 Global Prokinetic Drug Price by Application

5.3.1 Global Prokinetic Drug Price by Application (2019-2024)

5.3.2 Global Prokinetic Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Prokinetic Drug Market Size by Type

6.1.1 US & Canada Prokinetic Drug Sales by Type (2019-2030)

6.1.2 US & Canada Prokinetic Drug Revenue by Type (2019-2030)

6.2 US & Canada Prokinetic Drug Market Size by Application

6.2.1 US & Canada Prokinetic Drug Sales by Application (2019-2030)

6.2.2 US & Canada Prokinetic Drug Revenue by Application (2019-2030)

6.3 US & Canada Prokinetic Drug Market Size by Country

6.3.1 US & Canada Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Prokinetic Drug Sales by Country (2019-2030)

6.3.3 US & Canada Prokinetic Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Prokinetic Drug Market Size by Type

7.1.1 Europe Prokinetic Drug Sales by Type (2019-2030)

7.1.2 Europe Prokinetic Drug Revenue by Type (2019-2030)

7.2 Europe Prokinetic Drug Market Size by Application

7.2.1 Europe Prokinetic Drug Sales by Application (2019-2030)

7.2.2 Europe Prokinetic Drug Revenue by Application (2019-2030)

7.3 Europe Prokinetic Drug Market Size by Country

7.3.1 Europe Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Prokinetic Drug Sales by Country (2019-2030)

7.3.3 Europe Prokinetic Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Prokinetic Drug Market Size

8.1.1 China Prokinetic Drug Sales (2019-2030)

8.1.2 China Prokinetic Drug Revenue (2019-2030)

8.2 China Prokinetic Drug Market Size by Application

8.2.1 China Prokinetic Drug Sales by Application (2019-2030)

8.2.2 China Prokinetic Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Prokinetic Drug Market Size by Type

9.1.1 Asia Prokinetic Drug Sales by Type (2019-2030)

9.1.2 Asia Prokinetic Drug Revenue by Type (2019-2030)

9.2 Asia Prokinetic Drug Market Size by Application

9.2.1 Asia Prokinetic Drug Sales by Application (2019-2030)

9.2.2 Asia Prokinetic Drug Revenue by Application (2019-2030)

9.3 Asia Prokinetic Drug Sales by Region

9.3.1 Asia Prokinetic Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Prokinetic Drug Revenue by Region (2019-2030)

9.3.3 Asia Prokinetic Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Prokinetic Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Prokinetic Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Prokinetic Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Prokinetic Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Prokinetic Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Prokinetic Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Prokinetic Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sumitomo

11.1.1 Sumitomo Company Information

11.1.2 Sumitomo Overview

11.1.3 Sumitomo Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sumitomo Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sumitomo Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson Overview

11.2.3 Johnson & Johnson Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Johnson & Johnson Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Johnson & Johnson Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Information

11.3.2 Sanofi Overview

11.3.3 Sanofi Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Sanofi Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Sanofi Recent Developments

11.4 Kyowa Kirin Pharmaceuticals

11.4.1 Kyowa Kirin Pharmaceuticals Company Information

11.4.2 Kyowa Kirin Pharmaceuticals Overview

11.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Kyowa Kirin Pharmaceuticals Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Overview

11.5.3 Pfizer Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Pfizer Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Pfizer Recent Developments

11.6 Teva

11.6.1 Teva Company Information

11.6.2 Teva Overview

11.6.3 Teva Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Teva Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Teva Recent Developments

11.7 Cadila Pharmaceuticals

11.7.1 Cadila Pharmaceuticals Company Information

11.7.2 Cadila Pharmaceuticals Overview

11.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Cadila Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Cadila Pharmaceuticals Recent Developments

11.8 Hanmi Pharm

11.8.1 Hanmi Pharm Company Information

11.8.2 Hanmi Pharm Overview

11.8.3 Hanmi Pharm Prokinetic Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Hanmi Pharm Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Hanmi Pharm Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Prokinetic Drug Industry Chain Analysis

12.2 Prokinetic Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Prokinetic Drug Production Mode & Process

12.4 Prokinetic Drug Sales and Marketing

12.4.1 Prokinetic Drug Sales Channels

12.4.2 Prokinetic Drug Distributors

12.5 Prokinetic Drug Customers

13 Market Dynamics

13.1 Prokinetic Drug Industry Trends

13.2 Prokinetic Drug Market Drivers

13.3 Prokinetic Drug Market Challenges

13.4 Prokinetic Drug Market Restraints

14 Key Findings in The Global Prokinetic Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sumitomo

Johnson & Johnson

Sanofi

Kyowa Kirin Pharmaceuticals

Pfizer Inc

TEVA

Cadila Pharmaceuticals

Hanmi Pharm

List of Tables

Table 1. Global Prokinetic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Metoclopramide

Table 3. Major Manufacturers of Domperidone

Table 4. Major Manufacturers of Cisapride

Table 5. Major Manufacturers of Others

Table 6. Global Prokinetic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Prokinetic Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Prokinetic Drug Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Prokinetic Drug Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Prokinetic Drug Revenue Market Share by Region (2019-2024)

Table 11. Global Prokinetic Drug Revenue Market Share by Region (2025-2030)

Table 12. Global Prokinetic Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Prokinetic Drug Sales by Region (2019-2024) & (K Units)

Table 14. Global Prokinetic Drug Sales by Region (2025-2030) & (K Units)

Table 15. Global Prokinetic Drug Sales Market Share by Region (2019-2024)

Table 16. Global Prokinetic Drug Sales Market Share by Region (2025-2030)

Table 17. Global Prokinetic Drug Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Prokinetic Drug Sales Share by Manufacturers (2019-2024)

Table 19. Global Prokinetic Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Prokinetic Drug Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Prokinetic Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Prokinetic Drug Price by Manufacturers 2019-2024 (US$/Unit)

Table 23. Global Prokinetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Prokinetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2023)

Table 25. Global Key Manufacturers of Prokinetic Drug, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Prokinetic Drug, Product Offered and Application

Table 27. Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 30. Global Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 31. Global Prokinetic Drug Sales Share by Type (2019-2024)

Table 32. Global Prokinetic Drug Sales Share by Type (2025-2030)

Table 33. Global Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Prokinetic Drug Revenue Share by Type (2019-2024)

Table 36. Global Prokinetic Drug Revenue Share by Type (2025-2030)

Table 37. Prokinetic Drug Price by Type (2019-2024) & (US$/Unit)

Table 38. Global Prokinetic Drug Price Forecast by Type (2025-2030) & (US$/Unit)

Table 39. Global Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 40. Global Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 41. Global Prokinetic Drug Sales Share by Application (2019-2024)

Table 42. Global Prokinetic Drug Sales Share by Application (2025-2030)

Table 43. Global Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Prokinetic Drug Revenue Share by Application (2019-2024)

Table 46. Global Prokinetic Drug Revenue Share by Application (2025-2030)

Table 47. Prokinetic Drug Price by Application (2019-2024) & (US$/Unit)

Table 48. Global Prokinetic Drug Price Forecast by Application (2025-2030) & (US$/Unit)

Table 49. US & Canada Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Prokinetic Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 62. Europe Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 63. Europe Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 64. Europe Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 67. Europe Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 68. Europe Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Prokinetic Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 74. Europe Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 75. China Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 76. China Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 77. China Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 80. China Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 81. China Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 84. Asia Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 85. Asia Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 88. Asia Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 89. Asia Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Prokinetic Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Prokinetic Drug Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Prokinetic Drug Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Prokinetic Drug Sales by Region (2019-2024) & (K Units)

Table 95. Asia Prokinetic Drug Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Prokinetic Drug Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Prokinetic Drug Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Prokinetic Drug Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Prokinetic Drug Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Prokinetic Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Prokinetic Drug Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Prokinetic Drug Sales by Country (2025-2030) & (K Units)

Table 109. Sumitomo Company Information

Table 110. Sumitomo Description and Major Businesses

Table 111. Sumitomo Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 112. Sumitomo Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Sumitomo Recent Developments

Table 114. Johnson & Johnson Company Information

Table 115. Johnson & Johnson Description and Major Businesses

Table 116. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 117. Johnson & Johnson Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Johnson & Johnson Recent Developments

Table 119. Sanofi Company Information

Table 120. Sanofi Description and Major Businesses

Table 121. Sanofi Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 122. Sanofi Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Sanofi Recent Developments

Table 124. Kyowa Kirin Pharmaceuticals Company Information

Table 125. Kyowa Kirin Pharmaceuticals Description and Major Businesses

Table 126. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 127. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Kyowa Kirin Pharmaceuticals Recent Developments

Table 129. Pfizer Company Information

Table 130. Pfizer Description and Major Businesses

Table 131. Pfizer Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 132. Pfizer Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Pfizer Recent Developments

Table 134. Teva Company Information

Table 135. Teva Description and Major Businesses

Table 136. Teva Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 137. Teva Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Teva Recent Developments

Table 139. Cadila Pharmaceuticals Company Information

Table 140. Cadila Pharmaceuticals Description and Major Businesses

Table 141. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 142. Cadila Pharmaceuticals Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Cadila Pharmaceuticals Recent Developments

Table 144. Hanmi Pharm Company Information

Table 145. Hanmi Pharm Description and Major Businesses

Table 146. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 147. Hanmi Pharm Prokinetic Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Hanmi Pharm Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Prokinetic Drug Distributors List

Table 152. Prokinetic Drug Customers List

Table 153. Prokinetic Drug Market Trends

Table 154. Prokinetic Drug Market Drivers

Table 155. Prokinetic Drug Market Challenges

Table 156. Prokinetic Drug Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Prokinetic Drug Product Picture

Figure 2. Global Prokinetic Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Prokinetic Drug Market Share by Type in 2023 & 2030

Figure 4. Metoclopramide Product Picture

Figure 5. Domperidone Product Picture

Figure 6. Cisapride Product Picture

Figure 7. Others Product Picture

Figure 8. Global Prokinetic Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Prokinetic Drug Market Share by Application in 2023 & 2030

Figure 10. Gastroparesis

Figure 11. Constipation

Figure 12. Reflux Esophagitis

Figure 13. Functional Dyspepsia

Figure 14. Prokinetic Drug Report Years Considered

Figure 15. Global Prokinetic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Prokinetic Drug Revenue 2019-2030 (US$ Million)

Figure 17. Global Prokinetic Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Prokinetic Drug Revenue Market Share by Region (2019-2030)

Figure 19. Global Prokinetic Drug Sales 2019-2030 ((K Units)

Figure 20. Global Prokinetic Drug Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Prokinetic Drug Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Prokinetic Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Prokinetic Drug Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Prokinetic Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Prokinetic Drug Sales YoY (2019-2030) & (K Units)

Figure 26. China Prokinetic Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Prokinetic Drug Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Prokinetic Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Prokinetic Drug Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Prokinetic Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Prokinetic Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Prokinetic Drug in the World: Market Share by Prokinetic Drug Revenue in 2023

Figure 33. Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 35. Global Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 36. Global Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 37. Global Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Prokinetic Drug Revenue Share by Country (2019-2030)

Figure 43. US & Canada Prokinetic Drug Sales Share by Country (2019-2030)

Figure 44. U.S. Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 47. Europe Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 48. Europe Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 49. Europe Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 50. Europe Prokinetic Drug Revenue Share by Country (2019-2030)

Figure 51. Europe Prokinetic Drug Sales Share by Country (2019-2030)

Figure 52. Germany Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 53. France Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 57. China Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 58. China Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 59. China Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 60. China Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 61. Asia Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 62. Asia Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 63. Asia Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 64. Asia Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 65. Asia Prokinetic Drug Revenue Share by Region (2019-2030)

Figure 66. Asia Prokinetic Drug Sales Share by Region (2019-2030)

Figure 67. Japan Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 71. India Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Prokinetic Drug Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Prokinetic Drug Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Prokinetic Drug Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Prokinetic Drug Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Prokinetic Drug Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Prokinetic Drug Sales Share by Country (2019-2030)

Figure 78. Brazil Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Prokinetic Drug Revenue (2019-2030) & (US$ Million)

Figure 83. Prokinetic Drug Value Chain

Figure 84. Prokinetic Drug Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Tranexamic Acid Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17W7451

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Moxifloxacin HCl Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-13144

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Prokinetic Drug Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-27V8237

Global Prokinetic Drug Market Insights, Forecast to 2030

FEATURED COMPANIES

Prokinetic Drug Market Size

Prokinetic Drug Market

Scope of Prokinetic Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Prokinetic Drug Market report?

What are the Application segmentation covered in the Prokinetic Drug Market report?

What are the Type segmentation covered in the Prokinetic Drug Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$8000

Enterprise User

Global Powertrain Testing Market Insights and Forecast to 2027

Single User, Electronic (PDF)